Neoplasias mieloproliferativas crónicas Filadelfia negativas
Medicine - Programa de Formación Médica Continuada Acreditado, ISSN: 0304-5412, Vol: 14, Issue: 20, Page: 1157-1170
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
En esta actualización se tratan en detalle el resto de las neoplasias mieloproliferativas (NMP) clásicas, denominadas NMP crónicas Filadelfia (Ph) negativas: policitemia vera, trombocitemia esencial y mielofibrosis primaria, y otras menos frecuentes como son la leucemia neutrofílica crónica (LNC) y la leucemia eosinofílica crónica (LEC). Las NMP se incluyen en la clasificación ICC ( International Consensus Classification ) dentro de la categoría de neoplasias mieloides y leucemias agudas de forma similar a la clasificación de neoplasias hematolinfoides de la OMS revisada en 2022. This update discusses in detail the remaining classic myeloproliferative neoplasms (MPNs), called Philadelphia (Ph)-negative chronic MPNs. They include polycythemia vera, essential thrombocythemia, primary myelofibrosis, and other less frequent conditions such as chronic neutrophilic leukemia (CNL) and chronic eosinophilic leukemia (CEL). MPNs are included in the ICC (International Consensus Classification) in the myeloid neoplasms and acute leukemia category, similar to the WHO classification of hematolymphoid neoplasms revised in 2022 1–3.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0304541224002695; http://dx.doi.org/10.1016/j.med.2024.10.020; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85208549519&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S0304541224002695; https://dx.doi.org/10.1016/j.med.2024.10.020
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know